The Development of Chronic Myelogenous Leukemia Tumor-Resistance to Gleevec Appears

The development of chronic myelogenous leukemia tumor-resistance to Gleevec appears to be a common occurence. What is presently thought to be the best drug regimen for treating chronic myelogenous leukemia?

A) a cocktail of several different inhibitors that target different parts of the Abl protein
B) a cocktail of several different inhibitors that target the same parts of the Abl protein
C) a cocktail of several different inhibitors that target common domains of different proteins
D) a cocktail of several different inhibitors that target the different parts of different proteins

Correct Answer:

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Access For Free